Brianna Abbott

Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates. The market for drugs designed to treat the deadliest gynecologi... See more

Data from children in Africa have helped uncover emerging, novel links between neurodevelopmental conditions and more than 30 genes, according to a new preprint. The findings are among the first from the NeuroDev study, which recruits participants from fa... See more

Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data are expected later this year. Pfizer arrived in Chicago this weekend for the American Society of Clinical Oncology’s annual confe... See more

Approval is based on SCORPIO-PEP, the only Phase 3 study of an oral antiviral to meet the primary endpoint of preventing symptomatic COVID-19 following exposure to an infected individual* XOCOVA offers a new approach to help prevent COVID-19 by blocking v... See more

First-in-human preliminary results showed SMP-3124LP was generally well-tolerated with manageable safety profile in patients with heavily pretreated advanced solid tumors Early signals of clinical activity observed with a 48.2% disease control rate (DCR) ... See more